New Real-World Data Show penKid Adding Decision Support for Kidney Replacement Therapy in Critical Care

A prospective real-world study of 1,436 critically ill ICU patients found penKid (proenkephalin A 119–159) provides clinically relevant information across AKI severity and during kidney replacement therapy (KRT), addressing an unmet need in KRT management. The article frames the results as supportive evidence for penKid’s utility in guiding KRT, but provides no quantified efficacy or commercialization metrics to suggest an immediate pricing catalyst.